#Comirnaty: EMA raccomanda l’approvazione del #vaccino #COVID19 adattato contro Omicron XBB.1.5
#UnoSalute

📌 Il vaccino sarà utilizzato negli adulti e nei bambini a partire dai 6 mesi.

📌 gli adulti e i bambini di età = o > 5 anni devono ricevere un’unica dose, a prescindere da un eventuale precedente ciclo vaccinale

📌 I bambini di età compresa tra 6m e 4a possono ricevere una oppure tre dosi, se abbiano completato il ciclo di vaccinazione primaria o avuto COVID-19.

https://www.aifa.gov.it/-/comirnaty-ema-raccomanda-l-approvazione-del-vaccino-covid-19-adattato-contro-omicron-xbb.1.5

EMA’s human medicines committee (CHMP) has recommended authorising an adapted #Comirnaty #vaccine targeting the Omicron XBB.1.5 subvariant for preventing #COVID19 in adults and children from 6mo of age.

Adults and children from 5 yrs who require vaccination should have a single dose, irrespective of their COVID-19 vaccination history.

Children from 6mo-4yrs may have 1 or 3 doses depending on whether they have completed a primary vaccination course or have had COVID-19.

https://www.ema.europa.eu/en/news/comirnaty-ema-recommends-approval-adapted-covid-19-vaccine-targeting-omicron-xbb15

Germany: BioNTech COVID vaccine damages trial begins

https://www.dw.com/en/germany-biontech-covid-vaccine-damages-trial-begins/a-65886978?maca=en-dipa_news_mstdn-34613-xml-mrss

#coronavirus #Comirnaty #BioNTech #COVID-19 #Coronavirusvaccine

Der 2. BA5/4 #Booster hatte mich ausgeknockt. Die Body Batterie lud selbst nachts nicht mehr. Nun ist alles wieder im Lot.
#covidisnotoveryet #COVID19 #Comirnaty #impfung

Nummer 6 #Comirnaty

Ach übrigens: Seit Freitag bin ich zum 5. Mal gegen #Covid geimpft und habe damit jetzt auch das letzte #Omikron-Update intus. Der #Impfstoff ist gleichzeitig auch #Booster für die früheren Impfungen. #Impfreaktionen: Keine, nicht mal der Arm tut weh.

#Corona #comirnaty

@pivoinebleue While Pfizer didn't even develop an own vaccine - they're just reproducing Germany's Biontech-developed vaccines.
So there's no reason to claim horrendous development costs falsely justifying monstrous price hikes.
What there is instead is self-managed greed & medical highway robbery.

#SaveLives #COVID #Vaccines #CrisisProfiteering #Comirnaty #Biontech #Pfizer

Sostienici Tutti noi di Eventi Avversi News vogliamo che siate sempre aggiornati. La nostra missione non è solo quella di tenere i riflettori accesi, noi vogliamo fornirvi i migliori contenuti. Se apprezzate il nostro lavoro e volete sostenerci, potete farlo con una libera donazione.
La circolar...
https://parliamodi.news/detail/7592.html
#14Gennaio #Cronaca #Ba.4eBa.5 #bambini #Comirnaty

五个城市的在华常住德籍公民 将可接种复必泰mRNA新冠疫苗了

2022-12-22 第一财经
https://www.yicai.com/news/101631424.html

12月22日晚间，复星医药（600196.SH，02196.HK）和BioNTech SE（下称"BioNTech"）共同宣布，由两家公司供应的约1.15万复必泰mRNA新冠疫苗，已于2022年12月21日运抵中国北京，具体包括针对Omicron BA.4/BA.5变异株的复必泰二价疫苗和复必泰单价疫苗BNT162b2。

第一财经记者从复星医药了解到，随着上述两款疫苗运抵北京，预计将在北京、上海、广州、沈阳和成都为在华常住德籍公民提供复必泰新冠疫苗接种服务。

BioNTech首席业务及商务官Sean Marett表示，“非常感谢中德两国政府的共同努力和支持，帮助我们为在华常住德籍公民提供复必泰单价疫苗和复必泰二价疫苗。随着疫苗运抵中国北京，对于BioNTech以及我们的合作伙伴复星医药来说，这是在抗击新冠疫情路上的又一个重要里程碑。”

复星医药执行总裁兼CGO李胜利表示，“自新冠疫情暴发以来，我们和BioNTech始终紧密合作，共同推进mRNA疫苗复必泰在中国的临床试验及注册申请。很高兴我们能与BioNTech携手为在华常住德籍公民提供复必泰疫苗接种服务，这是我们全球合作共同抵御新冠疫情的又一里程碑。”

早在2020年3月16日，复星医药和德国企业BioNTech宣布达成了mRNA疫苗开发的战略合作。

2022年12月，mRNA新冠疫苗复必泰BNT162b2以及复必泰二价疫苗均获正式注册为中国香港药品/制品（生物制品）。其中，复必泰BNT162b2获注册用于12岁及以上人群的基础免疫接种、复必泰二价疫苗获注册用于12岁及以上人群的加强接种。本次在中国香港注册后，有接种意愿的人士可凭当地医生处方于位于中国香港的医疗机构或诊所接种复必泰疫苗。这也意味着，自中国澳门2022年11月1日开放自费接种复必泰疫苗后，中国内地居民也可以去中国香港接种复必泰疫苗加强针

复必泰二价疫苗是已上市复必泰BNT162b2的迭代和补充，复必泰二价疫苗含有15微克原始新冠病毒刺突蛋白的mRNA编码以及15微克Omicron BA.4/BA.5变异株刺突蛋白的mRNA编码。

不过值得一提的是，截至目前，mRNA新冠疫苗复必泰BNT162b2以及复必泰二价疫苗尚未获批在中国内地上市。

#复星 #复必泰 #BioNTech #辉瑞 #Pfizer #Comirnaty #疫苗 #EUA

Transparenz bei Impfstoffherstellern? Fehlanzeige!

Pfizer CEO Bourla lehnt (zum zweiten Mal) eine Anhörung im Sonderausschuss COVID des EU-Parlaments ab. Dabei sollte es nicht nur um ungeklärte Fragen zu Zulassungsstudien gehen, sondern auch um seine weiterhin geheimgehaltene Kommunikation mit Frau Leyen zu milliarden-schweren Impfstoff-Deals.

Zusammen mit den geleakten Knebel- und Geheimverträgen ergibt sich hier ein Bild der Impfstoff-Industrie, das an Organisationen aus Sizilien erinnert.

https://www.politico.eu/article/pfizer-ceo-albert-bourla-pulls-out-of-testifying-to-eu-parliament-covid-panel/amp/

https://www.infosperber.ch/wirtschaft/konzerne/impfstoffe-knebelvertraege-sollten-10-jahre-geheim-bleiben/

#mezis #pfizer #covid #comirnaty #leyen #bourla

No, you cannot be forced to take the newly “approved” #Comirnaty covid #vaccine from #Pfizer https://bit.ly/no-forced-comirnaty-covid-vaccine-from-pfizer

No, you cannot be forced to take the newly “approved” #Comirnaty covid #vaccine from #Pfizer https://bit.ly/no-forced-comirnaty-covid-vaccine-from-pfizer

#FakeNewsErwischt
Nein, #Pfizer hat nicht zugegeben, dass der #Corona-#Impfstoff #Comirnaty nicht schützt
https://correctiv.org/faktencheck/2022/11/14/nein-pfizer-hat-nicht-zugegeben-dass-der-corona-impfstoff-comirnaty-nicht-schuetzt/

#Vaccination edition of "Gotta have it both ways" (an obscure german comedy reference that doesn't translate well into english :-)).

Just got the #Coronavirus #booster vaccination by Moderna (#comirnaty vs. #wildtype & #BA4/#BA5) in one arm and the current #influenca quad-vaccination in the other (#InflusplitTetra2022-2023)

Vaccination? Get 'er done.

#SARSCoV2 #Influenca #vaccination

EMA has published #ClinicalData supporting the authorisation of the adapted #Comirnaty #COVID19vaccine targeting the #Omicron subvariant BA.1.
👉https://clinicaldata.ema.europa.eu/web/cdp/home

🐦🔗: https://nitter.eu/EMA_News/status/1585908498499444736

📢Just published ❗️ - #ClinicalData supporting the use of #Comirnaty as a #BoosterDose for children aged 5 to 11 are now available.
@GovCanHealth
👉https://clinicaldata.ema.europa.eu/web/cdp/home

🐦🔗: https://nitter.eu/EMA_News/status/1584928181626097667

RT @EMA_News: EMA has published #ClinicalData supporting the authorisation of the adapted #Comirnaty #COVID19vaccine targeting the #Omicron subvariant BA.1.
👉https://clinicaldata.ema.europa.eu/web/cdp/home

🐦🔗: https://nitter.eu/ECDC_EU/status/1585911633511174144

RT @EMA_News: EMA has published #ClinicalData supporting the authorisation of the adapted #Comirnaty #COVID19vaccine targeting the #Omicron subvariant BA.1.
👉https://clinicaldata.ema.europa.eu/web/cdp/home

🐦🔗: https://nitter.eu/EU_Health/status/1585913816268808193

RT @EMA_News: 📢Just published ❗️ - #ClinicalData supporting the use of #Comirnaty as a #BoosterDose for children aged 5 to 11 are now available.
@GovCanHealth
👉https://clinicaldata.ema.europa.eu/web/cdp/home

🐦🔗: https://nitter.eu/ECDC_EU/status/1585172673427931136

RT @EMA_News: 📢Just published ❗️ - #ClinicalData supporting the use of #Comirnaty as a #BoosterDose for children aged 5 to 11 are now available.
@GovCanHealth
👉https://clinicaldata.ema.europa.eu/web/cdp/home

🐦🔗: https://nitter.eu/EU_Health/status/1585153093414494208